North Brunswick, NJ, United States of America

Seymour D Levine

This inventor holds 18 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Ortho Pharmaceutical Corporation, E. R. Squibb Sons, Inc.. Active years: 1976-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seymour D Levine. Retrieved from https://idiyas.com/inventor/seymour-d-levine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 4

Forward Citations = 70(Granted Patents)

Location History:

North Brunswick, NJ (US) (1976 - 1987)
Culver City, CA (US) (2007)

Company Filing History:

12 out of 377

Ortho Pharmaceutical Corporation

patents

5 out of 1,624

E. R. Squibb Sons, Inc.

patents

where one patent can have more than one assignee

Years Active: 1976-2007

Loading Chart...

Areas of Expertise:

Quinazolinones

Pharmaceutical Compositions

Steroidal Compounds

Arrhythmia Treatment

Plant Extracts

Azabicyclic Compounds

Maintenance Systems

Dioxanes

Alkanoic Acids

Synthesis

Analino Compounds

Utero-Evacuant Substances

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE39618 - Remote, aircraft, global, paperless maintenance system (2007-05-07),

2. 4656267 - Substituted 2(1H)-quinazolinone-1-alkanoic acids and esters (1987-04-07),

3. 4631283 - Ortho substituted dihydroxy-2(1H)quinazolinone-1-alkanoic acids (1986-12-23),

4. 4556739 - 3,4-Dialkoxy-2-alkylcarbonyl analino compounds (1985-12-03),

5. 4555571 - Substituted 2(1H)-quinazolinone-1-alkanoic acids and esters (1985-11-26),

6. 4555570 - Substituted 4-alkyl-2-(1H) quinazolinone-1-alkanoic acid derivatives (1985-11-26),

7. 4490374 - 5,6-Dialkoxy-3,4-optionally substituted-2(1H)quinazolinones, composition (1984-12-25),

8. 4307019 - Total synthesis of (1981-12-22),

9. 4277401 - Total synthesis of (1981-07-07),

10. 4250180 - Method of treating arrhythmia (1981-02-10),

11. 4129653 - Substituted pyrrolo [1,2-c] quinazolines and pharmaceutical compositions (1978-12-12),

12. 4127589 - 4,5-Seco-steroids (1978-11-28),

13. 4061739 - Isolation of utero-evacuant substances from plant extracts (1977-12-06),

14. 4057547 - Azabicyclic compounds, and production thereof (1977-11-08),

15. 4052436 - Fluorene-2-acetic acids and derivatives, process and method of using (1977-10-04),

Title: Seymour D. Levine: Innovator in Aviation and Cardiovascular Solutions

Introduction

Seymour D. Levine is a notable inventor based in North Brunswick, NJ (US), recognized for his contributions to aviation technology and cardiovascular medicine. With a total of 18 patents, Levine has made significant advancements that enhance safety and efficiency in aircraft operations, as well as improvements in renal health.

Latest Patents

One of Levine's latest inventions is a remote, aircraft, global, paperless maintenance system. This innovative system monitors various performance parameters and operational metrics of aircraft, broadcasting critical information such as aircraft identification, audio, video, global positioning, and altitude data to a worldwide two-way RF network. The data is monitored and recorded at a centralized location, where it is combined with archived data, ATC data, weather data, topological data, map data, and manufacturers' data. This comprehensive analysis allows for the identification of potential problems and the generation of six types of advisories: maintenance, safety of flight, flight efficiency, flight separation, safe to fly, and safe to take off. In the event of a crash, the remotely recorded data provides immediate insights into the cause and location of the incident. This invention not only replaces traditional on-board flight data recorders, saving costs and weight, but also enhances aircraft separation control and flight efficiency.

Another significant patent involves the synthesis of substituted 2(1H)-quinazolinone-1-alkanoic acids and their esters. These novel quinazolinones act as renal vasodilators, effectively reducing vascular resistance to renal blood flow. As cardiovascular agents, they hold promise for improving heart health.

Career Highlights

Throughout his career, Levine has worked with prominent companies such as Ortho Pharmaceutical Corporation and E.R. Squibb & Sons, Inc. His experience in these organizations has contributed to his innovative mindset and ability to develop groundbreaking solutions.

Collaborations

Levine has collaborated with notable colleagues, including Victor T. Bandurco and Dennis M. Mulvey. These partnerships have likely fostered an environment of creativity and innovation, leading to the development of his impactful inventions.

Conclusion

Seymour D. Levine's contributions to aviation and cardiovascular health exemplify the spirit of innovation. His patents not only enhance safety and efficiency in aircraft operations but also offer potential benefits in medical applications

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]